Brexit Ambiguity A Top Priority For Bayer's New UK & Ireland CEO

Lars Bruening, who recently succeeded Alexander Moscho as Bayer's CEO for the UK and Ireland, talks to Scrip about Brexit uncertainties and fostering the right dialog between pharma and healthcare systems.

EU & UK
Lars Bruening takes the helm at Bayer UK & Ireland in time of change • Source: Shutterstock

More from Strategy

More from Business